It’s been a relatively muted week in terms of company news, but the second psychedelics-tinged ETF has now seen its first full week of trading on the US NYSE Arca exchange. In the Weekend Reading section we cover a recent poll that shows widespread support for psilocybin research and rescheduling among the British public. British MP Crispin Blunt shared his opinions on this poll in an Op-ed for…


Previous articleDelix Therapeutics Announces Scientific & Strategic Advisory Board Appointments
Next articleTolerance, Tachyphylaxis, and Psychedelic Drug Action